Home  »  Companies   »  Guardant Health Inc. (GH) Is A Stock Worth Conside...

Guardant Health Inc. (GH) Is A Stock Worth Considering For The Coming Weeks

Guardant Health Inc. (NASDAQ:GH) concluded the trading at $30.76 on Thursday, September 14 with a fall of -4.62% from its closing price on previous day.

Taking a look at stock we notice that its last check on previous day was $32.25 with its price kept floating in the range of $30.375 and $32.64 on the day. Considering stock’s 52-week price range provides that GH hit a high price of $62.75 and saw its price falling to a low level of $20.67 during that period. Over a period of past 1-month, stock came subtracting -13.08% in its value.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.

Sponsored

With its current market valuation of $3.79 billion. Analysts are in estimates of -$0.94 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$3.86 for 2023 with estimates of that growing to -$3.42 in next year. These estimates are suggesting current year growth of 39.80% for EPS and 11.40% growth next year.

Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of $137.2 million. They suggested that in the process company could generate revenue of as low as $130.3 million which could climb up to $143.1 million to hit a high. The average estimate is representing an increase of 16.50% in sales growth from that of posted by the company in the same quarter of last year. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of $548.83 million in 2023, which will be 22.10% more from revenue generated by the company last year.

In last 7 days, analysts came adjusting their opinions about stock’s EPS with 2 upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review GH stock’s current outlook then short term indicators are assigning it an average of Hold, while medium term indicators are categorizing the stock at an average of 50% Buy. Long term indicators are suggesting an average of 50% Sell for it.

Digging deeper we become aware of the PEG ratio of the GH stock which is currently positioned at 0. It further provides that stock’s current price level is -15.06% away from its 20-day simple moving average and is -16.63% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 30.57 while volatility remained at 4.63% over the past week which changes to 5.61% when measuring it over the past month. Beta is valued at 0.88, while measure of average true range or ATR is currently at 1.89.

Having a second look at Guardant Health Inc. (NASDAQ:GH) provides that stock’s average daily trading volume for 3 months was 1.73 million, while it jumped to 2.24 million when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 117.69 million.

The percentage of outstanding shares held by the insiders is 0.10% while it is 94.00% for the institutional holders. The figures also indicate that as of Aug 30, 2023, number of stock’s short shares was 7.01 million which implies a short ratio of 5.35. This shows down a 5.96% of Short Interest in company’s outstanding shares on the day. In August the standing of shares short improved as it was 7.45 million in the previous month. Addition of 13.09% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.